University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Knowledge Base > Cardiac Risk > Cardiac Risk: Related Resources
Managing Medical Conditions Associated with Cardiac Risk in Patients with HIV: Related Resources
Back to Chapter
arrow imageRelated Knowledge Base Chapters
arrow imageJournal Articles
arrow imageGuidelines and Best Practices
arrow imagePresentations, Interviews, and Roundtable Discussions
arrow imageOnline Books and Chapters
arrow imageClinician Support Tools
grey line
Related Knowledge Base Chapters
Managing Medical Conditions Associated with Cardiac Risk in Patients with HIV
Daniel Wlodarczyk, MD, August 2004.
Journal Articles
Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy. van Vonderen MG, Smulders YM, Stehouwer CD, et al. J Acquir Immune Defic Syndr. 2009 Feb;50(2):153-161
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).
Worm SW, De Wit S, Weber R, et at. Circulation. 2009 Feb 17;119(6):805-11.
Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures.
De Lorenzo F, Collot-Teixeira S, Boffito M, et at. Curr Med Chem. 2008;15(28):2991-9.
Cardiovascular manifestations in human immunodeficiency virus-infected patients.
Khunnawat C, Mukerji S, Havlichek D Jr, et at. Am J Cardiol. 2008 Sep 1;102(5):635-42.
Screening and assessment of coronary heart disease in HIV-infected patients.
Hsue PY, Squires K, Bolger AF, et at; Working Group 4. Circulation. 2008 Jul 8;118(2):e41-7.
Prevention strategies for cardiovascular disease in HIV-infected patients.
Stein JH, Hadigan CM, Brown TT, et al; Working Group 6. Circulation. 2008 Jul 8;118(2):e54-60.
Guidelines and Best Practices
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
Nathan DM, Buse JB, Davidson MB, et al. Diabetologia. 2009 Jan;52(1):17-30.
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. NIH Publication No. 02-5215. September 2002.
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.
Rosendorff C, Black HR, Cannon CP, et al. Circulation. 2007 May 29;115(21):2761-88.
Presentations, Interviews, and Roundtable Discussions
Interesting Cases in HIV Clinical Pharmacology
Ian R. McNicholl, PharmD, BCPS. A presentation from the Positive Health Program Grand Rounds at San Francisco General Hospital, 11/3/05.
Online Books and Chapters
Primary Care of Veterans with HIV
A practical approach to the screening and treatment of comorbid conditions, including diabetes and hypertension, in people with HIV. U.S. Department of Veterans Affairs, 2009.
Dyslipidemia Section: Clinical Manual for Management of the HIV-Infected Adult
AIDS Education and Training Centers National Resource Center, 2006.
Insulin Resistance and Hyperglycemia on Antiretroviral Therapy Section: Clinical Manual for Management of the HIV-Infected Adult
AIDS Education and Training Centers National Resource Center, 2006.
Clinician Support Tools
Database of Antiretroviral Drug Interactions
HIV InSite's fully referenced searchable database of interactions involving at least one antiretroviral drug. Provides information regarding effects on drug levels, potential clinical effects, mechanisms of interaction, management tips, and suggested alternative agents.
Risk Assessment Tool for Estimating 10-year Risk of Developing Hard CHD
National Cholesterol Education Program, 2002, updated 2004.

About | Site Map | Feedback | Subscribe | Donate | Disclaimer

UCSF - Center for HIV Information HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2013, Regents of the University of California.